المؤلفون: Pousias S., Messini C.I., Anifandis G., Sveronis G., Georgoulias P., Daponte A., Messinis I.E., Dafopoulos K.

المصدر: Reproductive BioMedicine Online ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065887401&doi=10.1016%2fj.rbmo.2019.03.100&partnerID=40&md5=f1ec7ef256d1033e47b906fed4e39789

مصطلحات موضوعية: estradiol, follitropin, ganirelix, luteinizing hormone, gonadorelin, hormone antagonist, adult, Article, clinical article, controlled study, estradiol blood level, female, follicular phase, follitropin blood level, human, human cell, luteinizing hormone blood level, luteinizing hormone release, menstrual cycle, ovary follicle maturation, ovulation, transvaginal echography, blood, cell size, clinical trial, cytology, dose response, drug effect, normal human, ovary

Relation: http://hdl.handle.net/11615/78353

الاتاحة: http://hdl.handle.net/11615/78353
https://doi.org/10.1016/j.rbmo.2019.03.100